Julie A. McEarchern

1.3k total citations
25 papers, 1.0k citations indexed

About

Julie A. McEarchern is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Julie A. McEarchern has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in Julie A. McEarchern's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Lymphoma Diagnosis and Treatment (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Julie A. McEarchern is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Lymphoma Diagnosis and Treatment (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Julie A. McEarchern collaborates with scholars based in United States, Netherlands and South Korea. Julie A. McEarchern's co-authors include Iqbal S. Grewal, Che‐Leung Law, Kerry Klussman, Maureen C. Ryan, Ivan J. Stone, Kristine A. Gordon, David G. Besselsen, Emmanuel T. Akporiaye, Weiping Zeng and Tamar E. Boursalian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Julie A. McEarchern

24 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. McEarchern United States 13 537 387 384 294 189 25 1.0k
Susanne Hipp Germany 15 459 0.9× 717 1.9× 298 0.8× 195 0.7× 220 1.2× 22 1.2k
Zhengxing Qu United States 13 336 0.6× 230 0.6× 261 0.7× 465 1.6× 200 1.1× 17 822
Geneviève Fiol France 13 328 0.6× 489 1.3× 489 1.3× 120 0.4× 107 0.6× 16 1.1k
Stefan Knackmuss Germany 23 660 1.2× 534 1.4× 485 1.3× 640 2.2× 168 0.9× 41 1.4k
Klaus Brischwein Germany 17 1.1k 2.0× 451 1.2× 582 1.5× 728 2.5× 123 0.7× 21 1.5k
Thomas Hawthorne United States 20 660 1.2× 274 0.7× 421 1.1× 226 0.8× 85 0.4× 40 1.2k
Bart E.C.G. de Goeij Netherlands 8 408 0.8× 322 0.8× 189 0.5× 468 1.6× 67 0.4× 10 788
Kimberly H. Harrington United States 11 492 0.9× 343 0.9× 206 0.5× 254 0.9× 55 0.3× 17 807
Diane Tseng United States 11 701 1.3× 417 1.1× 803 2.1× 91 0.3× 80 0.4× 21 1.5k
Christina Krupka Germany 13 861 1.6× 398 1.0× 594 1.5× 198 0.7× 78 0.4× 25 1.3k

Countries citing papers authored by Julie A. McEarchern

Since Specialization
Citations

This map shows the geographic impact of Julie A. McEarchern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. McEarchern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. McEarchern more than expected).

Fields of papers citing papers by Julie A. McEarchern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. McEarchern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. McEarchern. The network helps show where Julie A. McEarchern may publish in the future.

Co-authorship network of co-authors of Julie A. McEarchern

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. McEarchern. A scholar is included among the top collaborators of Julie A. McEarchern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. McEarchern. Julie A. McEarchern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutherland, May S.K., Roland B. Walter, Scott C. Jeffrey, et al.. (2012). SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML. Blood. 120(21). 3589–3589. 7 indexed citations
2.
3.
Lewis, Timothy S., Kim K. Emmerton, Jeffrey Lau, et al.. (2011). Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(14). 4672–4681. 27 indexed citations
4.
Lewis, Timothy S., Weiping Zeng, Jamie B. Miyamoto, et al.. (2011). Abstract 1789: Auristatin-based antibody-drug conjugates are synergistic in combination with PI3K-AKT-mTOR pathway inhibitors in hematologic malignancies and carcinoma. Cancer Research. 71(8_Supplement). 1789–1789. 1 indexed citations
5.
Ryan, Maureen C., Heather Kostner, Karen A. Gordon, et al.. (2010). Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75. British Journal of Cancer. 103(5). 676–684. 68 indexed citations
6.
7.
Oflazoglu, Ezogelin, Tamar E. Boursalian, Weiping Zeng, et al.. (2009). Blocking of CD27-CD70 Pathway by Anti-CD70 Antibody Ameliorates Joint Disease in Murine Collagen-Induced Arthritis. The Journal of Immunology. 183(6). 3770–3777. 47 indexed citations
8.
Law, Che‐Leung, Julie A. McEarchern, & Iqbal S. Grewal. (2009). Novel Antibody-Based Therapeutic Agents Targeting CD70: A Potential Approach for Treating Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 90–93. 4 indexed citations
9.
Boursalian, Tamar E., Julie A. McEarchern, Che‐Leung Law, & Iqbal S. Grewal. (2009). Targeting CD70 for Human Therapeutic Use. Advances in experimental medicine and biology. 647. 108–119. 36 indexed citations
10.
McEarchern, Julie A., Leia M. Smith, Charlotte F. McDonagh, et al.. (2008). Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70. Clinical Cancer Research. 14(23). 7763–7772. 70 indexed citations
11.
Ho, Allen W., Evdoxia Hatjiharissi, Bryan Ciccarelli, et al.. (2008). CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia. Blood. 112(12). 4683–4689. 56 indexed citations
12.
Hatjiharissi, Evdoxia, Allen W. Ho, Lian Xu, et al.. (2006). Preclinical In Vitro and In Vivo Evidence Support a Therapeutic Role for the CD70 Directed Monoclonal Antibody (SGN-70) in Waldenstrom’s Macroglobulinemia (WM).. Blood. 108(11). 2490–2490. 2 indexed citations
13.
McEarchern, Julie A., Ezogelin Oflazoglu, Leigh Francisco, et al.. (2006). Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. Blood. 109(3). 1185–1192. 87 indexed citations
14.
McEarchern, Julie A., Charlotte F. McDonagh, Leia M. Smith, et al.. (2006). SGN-70, a Humanized Anti-CD70 Antibody, Targets CD70-Expressing Hematologic Tumors.. Blood. 108(11). 2492–2492. 1 indexed citations
15.
Law, Che‐Leung, Julie A. McEarchern, Charles G. Cerveny, et al.. (2005). The Humanized Anti-CD40 Monoclonal Antibody SGN-40 Targets Hodgkin’s Disease Cells through Multiple Mechanisms.. Blood. 106(11). 1476–1476. 5 indexed citations
16.
McEarchern, Julie A., Charlotte F. McDonagh, Allen W. Ho, et al.. (2005). A Humanized Anti-CD70 Monoclonal Antibody Targets CD70-Expressing Multiple Myeloma.. Blood. 106(11). 1591–1591. 4 indexed citations
17.
Zhou, Yaling, Julie A. McEarchern, Edward D. Howard, et al.. (2003). Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses. Cancer Immunology Immunotherapy. 52(7). 413–422. 8 indexed citations
18.
Wu, R., et al.. (2001). Comparative analysis of IFN- γ B7.1 and antisense TGF- β gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma. Cancer Immunology Immunotherapy. 50(5). 229–240. 35 indexed citations
19.
McEarchern, Julie A., James J. Kobie, Vivian Mack, et al.. (2000). Invasion and metastasis of a mammary tumor involves TGF-? signaling. International Journal of Cancer. 91(1). 76–82. 127 indexed citations
20.
McEarchern, Julie A., David G. Besselsen, & Emmanuel T. Akporiaye. (1999). Interferon γ and antisense transforming growth factor β transgenes synergize to enhance the immunogenicity of a murine mammary carcinoma. Cancer Immunology Immunotherapy. 48(2-3). 63–70. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Hipp Breakdown of academic impact, for papers by Zhengxing Qu Breakdown of academic impact, for papers by Geneviève Fiol Breakdown of academic impact, for papers by Stefan Knackmuss Breakdown of academic impact, for papers by Klaus Brischwein Breakdown of academic impact, for papers by Thomas Hawthorne Breakdown of academic impact, for papers by Bart E.C.G. de Goeij Breakdown of academic impact, for papers by Kimberly H. Harrington Breakdown of academic impact, for papers by Diane Tseng Breakdown of academic impact, for papers by Christina Krupka
Rankless by CCL
2026